Seasoned life sciences executive to lead MDS's largest business
TORONTO, April 27 /PRNewswire-FirstCall/ - MDS Inc. (NYSE: MDZ;
TSX: MDS), a leading provider of enabling products and services to the global
life sciences markets, announced today that David Spaight has joined as
President of MDS Pharma Services, effective immediately. Mr. Spaight will
report directly to Stephen P. DeFalco, President and Chief Executive Officer
of MDS Inc.
Mr. Spaight brings over 20 years of experience in the life sciences
industry. Most recently, he served as Senior Vice - President, Global Sales
and Marketing at Fisher Scientific Products, where he was responsible for the
integration of the sales, marketing, and research and development teams in
North America, Europe and Asia. Prior to joining Fisher, Mr. Spaight had an
extensive career at PerkinElmer, Inc. where he rose up through sales,
marketing, and general management positions to the role of Vice - President,
Global Sales and Marketing. In this role he led a global workforce of over
1400 people, in 40 countries and was responsible for $1.1 B in revenues.
Mr. Spaight has extensive experience in business development and operational
improvement. Mr. Spaight has a Bachelor of Science in Chemistry and a Masters
in Business Administration, both from the University of Michigan.
"David brings deep expertise in the global life sciences industry and an
impressive track record of success," said Stephen P. DeFalco, President and
CEO, MDS Inc. "His appointment comes at a crucial stage for MDS Pharma
Services, as we continue to reposition the business and improve operating
results."
"I am excited to join MDS Pharma Services at this time of tremendous
opportunity. Together with the management team, we will build on MDS Pharma
Service's market-leading positions and drive to top quartile performance,"
said Mr. Spaight.
Gilbert Godin, former President of MDS Pharma Services, is leaving the
Company to pursue a leadership opportunity in the specialty pharmaceutical
industry.
About MDS Pharma Services
MDS Pharma Services offers a full spectrum of resources to meet the drug
discovery and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around the world,
the company applies advanced scientific and technological expertise to each
stage of the drug discovery and development process - Early Stage: lead
optimization, pre-IND research, pharmaceutical and biopharmaceutical
development, early clinical research (bioequivalence, phases I-IIa) and
bioanalysis; and Late Stage: global clinical development (phases IIb-IV) and
central lab. For more information, visit MDS Pharma Services' Web site at
www.mdsps.com.
About MDS Inc.
MDS Pharma Services is an integral part of MDS Inc. (TSX: MDS; NYSE:
MDZ). MDS Inc. has more than 8,800 highly skilled people in 27 countries. We
provide a diverse range of superior products and services to increase our
customers' speed, precision and productivity in the drug development and
disease diagnosis processes. We are a global, values-driven life sciences
company, recognized for our reliability and collaborative relationships as we
help create better outcomes in the treatment of disease. Find out more at
www.mdsinc.com or by calling 1-800-MDS-7222, 24 hours a day.
SOURCE MDS Inc.
-0- 04/27/2006
/CONTACT: Sharon Mathers, Vice - President, Investor Relations and
External Communications, (416) 213-4721, Sharon.Mathers@mdsinc.com/
(MDS. MDZ)
CO: MDS Inc.
ST: Ontario
IN: HEA
SU: PER
-30-
KJ
-- TO137 --
7404 04/27/2006 07:00 EDT http://www.prnewswire.com
